Sara Picó

ORCID: 0000-0003-3022-8084
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Research and Splicing
  • Genetic Neurodegenerative Diseases
  • RNA and protein synthesis mechanisms
  • RNA regulation and disease
  • Pluripotent Stem Cells Research
  • Metabolism and Genetic Disorders
  • Mitochondrial Function and Pathology
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Genetics and Neurodevelopmental Disorders
  • Neurogenetic and Muscular Disorders Research
  • Parkinson's Disease Mechanisms and Treatments
  • Neurogenesis and neuroplasticity mechanisms
  • CRISPR and Genetic Engineering
  • Adipose Tissue and Metabolism
  • Neurological diseases and metabolism
  • Genomics and Chromatin Dynamics
  • RNA Interference and Gene Delivery
  • Pancreatic function and diabetes
  • Alcoholism and Thiamine Deficiency
  • Birth, Development, and Health
  • 3D Printing in Biomedical Research
  • Plant Genetic and Mutation Studies
  • Biochemical and Molecular Research
  • Tissue Engineering and Regenerative Medicine

University of Lausanne
2023-2024

Instituto de Salud Carlos III
2021-2024

Universidad Autónoma de Madrid
2018-2024

Biomedical Research Networking Center on Neurodegenerative Diseases
2021-2024

Centro de Biología Molecular Severo Ochoa
2018-2024

Instituto de Bioquímica Vegetal y Fotosíntesis
2015

Consejo Superior de Investigaciones Científicas
2015

Universidad de Sevilla
2015

Polycomb group (PcG) proteins play important roles in regulating developmental phase transitions plants; however, little is known about the role of PcG machinery transition from juvenile to adult phase. Here, we show that Arabidopsis (Arabidopsis thaliana) B lymphoma Moloney murine leukemia virus insertion region1 homolog (BMI1) POLYCOMB REPRESSIVE COMPLEX1 (PRC1) components participate repression microRNA156 (miR156). Loss AtBMI1 function leads up-regulation primary transcript MIR156A and...

10.1104/pp.15.00073 article EN PLANT PHYSIOLOGY 2015-04-20

Correction of mis-splicing events is a growing therapeutic approach for neurological diseases such as spinal muscular atrophy or neuronal ceroid lipofuscinosis 7, which are caused by splicing-affecting mutations. Mis-spliced effector genes that do not harbour mutations also good candidate targets in with more complex aetiologies cancer, autism, dystrophies neurodegenerative diseases. Next-generation RNA sequencing (RNA-seq) has boosted investigation global diseased tissue to identify key...

10.1093/brain/awab087 article EN cc-by-nc Brain 2021-03-12

The inclusion of microexons by alternative splicing occurs frequently in neuronal proteins. roles these sequences are largely unknown, and changes their degree associated with neurodevelopmental disorders1. We have previously shown that decreased a 24-nucleotide neuron-specific microexon CPEB4, RNA-binding protein regulates translation through cytoplasmic poly(A) tail length, is linked to idiopathic autism spectrum disorder (ASD)2. Why this required how small its dominant-negative effect on...

10.1038/s41586-024-08289-w article EN cc-by-nc-nd Nature 2024-12-04

Schizophrenia (SCZ) is caused by an interplay of polygenic risk and environmental factors, which may alter regulators gene expression leading to pathogenic misexpression SCZ genes. The CPEB family RNA-binding proteins (CPEB1-4) regulates translation target RNAs (approximately 40% overall genes). We previously identified CPEB4 as a key dysregulated translational regulator in autism spectrum disorder (ASD) because its neuronal-specific microexon (exon 4) mis-spliced ASD brains, causing...

10.1016/j.biopsych.2023.03.010 article EN cc-by-nc-nd Biological Psychiatry 2023-03-22

Aging is the major risk factor for most human diseases and represents a socio-economical challenge modern societies. Despite its importance, process of aging remains poorly understood. Epigenetic dysregulation has been proposed as key driver process. Modifications in transcriptional networks chromatin structure might be central to age-related functional decline. A prevalent feature described during overall reduction heterochromatin, specifically marked by loss repressive histone...

10.1101/2024.07.24.604929 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-07-24

The inclusion of microexons by alternative splicing is frequent in neuronal proteins. roles these sequences are most cases unknown, but changes their degree associated with neurodevelopmental diseases. We recently found that the decreased a 24-nucleotide neuron-specific microexon CPEB4, an RNA-binding protein regulates translation through cytoplasmic poly(A) tail length, linked to idiopathic autism spectrum disorder (ASD). Why this required and how small its generate dominant-negative effect...

10.1101/2023.03.19.532587 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-03-22

Abstract Several premature aging mouse models have been developed to study and identify interventions that can delay age‐related diseases. Yet, it is still unclear whether these truly recapitulate natural aging. Here, we analyzed DNA methylation in multiple tissues of four previously reported ( Ercc1 , LAKI Polg Xpg ). We estimated (DNAm) age samples using the Horvath clock. The most pronounced increase DNAm could be observed mice, a strain which exhibits deficit nucleotide excision repair....

10.1111/acel.14058 article EN cc-by Aging Cell 2023-12-22

Summary In vivo reprogramming through the forced expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) has demonstrated great potential for reversing age-associated phenotypes, as combination these transcription factors actively promote cell regeneration rejuvenation in various tissues organs. However, continuous OSKM raised safety concerns due to loss identity, decrease body weight, premature death. Although cyclic short-term or targeted can mitigate some detrimental effects mice, systemic wild...

10.1101/2024.03.08.584074 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-03-08

We have generated using CRISPR/Cas9 technology a partially humanized mouse model of the neurometabolic disease phenylketonuria (PKU), carrying highly prevalent PAH variant c.1066-11G>A. This creates an alternative 3' splice site, leading to inclusion 9 nucleotides coding for 3 extra amino acids between Q355 and Y356 protein. Homozygous Pah c.1066-11A mice, with intron 10 sequence variant, accurately recapitulate splicing defect present almost undetectable hepatic activity. They exhibit fur...

10.1093/hmg/ddae051 article EN cc-by Human Molecular Genetics 2024-03-23

SUMMARY In the last decade, cellular reprogramming of fully differentiated cells to pluripotent stem has become great interest. Importantly, by expression Oct4, Sox2, Klf4, and cMyc (OSKM) can ameliorate age-associated phenotypes in multiple tissues extend lifespan progeroid aged wild-type mice. Surprisingly, effects vivo have not been deeply investigated any other model organisms. Here, for first time, we induce C. elegans using a heat-inducible system at developmental adult stages. Similar...

10.1101/2024.05.03.592330 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-05-04

Abstract Age-associated neurodegenerative disorders represent significant challenges due to progressive neuronal decline and limited treatments. In aged mice, partial reprogramming, characterized by pulsed expression of reprogramming factors, has shown promise in improving function various tissues, but its impact on the aging brain remains poorly understood. Here we investigated vivo mature neurons dentate gyrus young mice. Using two different approaches – a neuron-specific transgenic...

10.1101/2024.07.24.604939 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-07-24

ABSTRACT Background Microexons are highly conserved and mostly neuronal-specific 3-27 nucleotide exons, enriched in genes linked to autism spectrum disorders (ASD). We have previously shown decreased inclusion of a neuronal specific 24 bp microexon (exon 4) the translational regulator CPEB4 brains idiopathic ASD cases that this leads aggregation subsequent under-expression multiple high confidence ASD-risk genes. Furthermore, enhanced skipping is also novel etiological mechanism...

10.1101/2024.10.25.620162 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-10-25

<title>Abstract</title> Aging is the major risk factor for most human diseases and represents a socio-economical challenge modern societies. Despite its importance, process of aging remains poorly understood. Epigenetic dysregulation has been proposed as key driver process. Alterations in transcriptional networks chromatin structure might be central to age-related functional decline. A prevalent feature described during overall reduction heterochromatin, specifically marked by loss...

10.21203/rs.3.rs-4012025/v1 preprint EN cc-by Research Square (Research Square) 2024-12-16

ABSTRACT Schizophrenia (SCZ) is caused by a complex interplay of polygenic risk and environmental factors, which might alter regulators gene expression leading to pathogenic mis-expression SCZ genes. The RNA binding protein family CPEB (CPEB1, CPEB2, CPEB3, CPEB4) regulates the translation target RNAs bearing CPE sequences in their 3’UTR (approximately 40% overall genes). We previously identified CPEB4 as key dysregulated translational regulator autism spectrum disorder (ASD), proving that...

10.1101/2022.09.22.508890 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2022-09-23

Abstract We have generated using CRISPR/Cas9 technology a partially humanized mouse model of the neurometabolic disease phenylketonuria (PKU), carrying highly prevalent PAH variant c.1066-11G&gt;A. This creates an alternative 3’ splice site, leading to inclusion 9 nucleotides coding for 3 extra amino acids between Q355 and Y356 protein. Homozygous Pah c.1066-11A mice, with intron 10 sequence variant, accurately recapitulate splicing defect present almost undetectable hepatic activity. They...

10.1101/2023.11.03.565447 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-11-05

<h3>Background</h3> Although promising gene-silencing therapies are being tested for Huntington's disease (HD), no disease-modifying treatments available. Thus, study of molecular mechanisms underneath <i>Htt</i>-mutation must continue to identify easily druggable targets. Cytoplasmic polyadenylation element binding proteins 1–4 (CPEB1–4) RNA-binding that repress or activate translation CPE-containing transcripts by shortening elongating their poly(A) tail. Alteration CPEB-dependent...

10.1136/jnnp-2021-ehdn.117 article EN 2021-09-01
Coming Soon ...